Newsfeeds - Spark Newswire

1 minute read

ClearPoint Neuro Q2 EPS $(0.17) Misses $(0.13) Estimate, Sales $3.41M Miss $3.68M Estimate

Today, 10:51 PM

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 54.55 percent decrease over losses of $(0.11) per share

CLPT

6 minute read

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts

By Shanthi Rexaline

Today, 10:51 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9)

ACET

10 minute read

Earnings Scheduled For August 10, 2021

By Benzinga Insights

Today, 10:51 PM

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.

ABST

2 minute read

General

ClearPoint Neuro, Inc. Announces Partnership With adeor medical AG; Co. To Act As Distributor In US For adeor’s Surgical Drill System

By Bill Haddad

Today, 10:51 PM

ClearPoint Neuro, Inc. (NASDAQ:CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it has entered into a strategic and commercial partnership with

CLPT

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 10:51 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 10:51 PM

Gainers

ADMP

1 minute read

News

ClearPoint Neuro: Return On Capital Employed Insights

By Benzinga Insights

Today, 10:51 PM

ClearPoint Neuro (NASDAQ:CLPT) reported Q1 sales of $4.03 million. Earnings fell to a loss of $2.18 million, resulting in a 3.72% decrease from last quarter. In Q4, ClearPoint Neuro brought in $3.72 million in sales but lost $2.27 million in earnings.

CLPT

1 minute read

News

ClearPoint Neuro Highlights Installation Of ClearPoint 2.0 Software At Mazowiecki Szpital Brodnowski In Poland

By Benzinga Newsdesk

Today, 10:51 PM

ClearPoint Neuro, Inc. (NASDAQ:CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its version 2.0 software at Mazowiecki Szpital

CLPT

1 minute read

News

ClearPoint Neuro Set To Join Russell 3000 Index June 28

By Benzinga Newsdesk

Today, 10:51 PM

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is set to join the broad-market Russell 3000 Index at the

CLPT

1 minute read

News

ClearPoint Neuro Insights: Return On Capital Employed

By Benzinga Insights

Today, 10:51 PM

During Q1, ClearPoint Neuro (NASDAQ:CLPT) brought in sales totaling $4.03 million. However, earnings decreased 3.72%, resulting in a loss of $2.18 million. ClearPoint Neuro collected $3.72 million in revenue during Q4, but reported earnings showed a $2.27 million loss.

CLPT